Literature DB >> 23021699

Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus.

Hilary A Roeder1, Thomas R Moore, Gladys A Ramos.   

Abstract

OBJECTIVE: We hypothesized that bolus and basal insulin doses in women with type 1 diabetes mellitus who use insulin pumps would increase 2-fold to maintain hemoglobin A1c <6.5% across gestation. STUDY
DESIGN: This was a retrospective study of 9 women with type 1 diabetes mellitus with preconceptional hemoglobin A1c ≤ 7.4% using insulin pumps. The primary outcome was absolute and percentage change of basal and bolus insulin from preconception to delivery.
RESULTS: Total daily dose of insulin increased from 33.3 ± 7.8 U/d before conception to 93.5 ± 27.9 U/d at delivery. Basal rates rose modestly (50% increase, from 16.2 ± 6.5 U/d to 24.0 ± 9 U/d); bolus insulin doses quadrupled from 17.1 ± 6.1 U/d to 69.5 ± 29.6 U/d (P = .0001). Bolus insulin increased from approximately 50% of total daily dose of insulin before conception to 75% of total daily dose of insulin at 36 weeks' gestation.
CONCLUSION: In well-controlled type 1 diabetes mellitus, insulin requirements increased 3-fold from before conception to 36 weeks' gestation. Most of this requirement was attributed to an increase in bolus rates that are required for control with meals.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021699     DOI: 10.1016/j.ajog.2012.06.029

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.

Authors:  Daoyin Dong; E Albert Reece; Xue Lin; Yanqing Wu; Natalia AriasVillela; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2015-09-30       Impact factor: 8.661

2.  Superoxide dismutase 1 overexpression in mice abolishes maternal diabetes-induced endoplasmic reticulum stress in diabetic embryopathy.

Authors:  Fang Wang; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2013-06-20       Impact factor: 8.661

Review 3.  Drugs to Control Diabetes During Pregnancy.

Authors:  Maisa N Feghali; Jason G Umans; Patrick M Catalano
Journal:  Clin Perinatol       Date:  2019-03-26       Impact factor: 3.430

4.  Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P Study.

Authors:  Ravinder Jeet Kaur; Byron H Smith; Basak Ozaslan; Jordan E Pinsker; Mari Charisse Trinidad; Grenye O'Malley; Donna Desjardins; Kristin N Castorino; Camilla Levister; Corey Reid; Shelly McCrady-Spitzer; Selassie J Ogyaadu; Mei Mei Church; Molly Piper; Walter K Kremers; Barak Rosenn; Francis J Doyle; Eyal Dassau; Carol J Levy; Yogish C Kudva
Journal:  Diabetes Technol Ther       Date:  2022-08       Impact factor: 7.337

Review 5.  Identifying Key Intervention Opportunities During a Pregnancy Complicated by Diabetes: a Review of Acute Complications of Diabetes During Pregnancy.

Authors:  Paige K Bradley; Marissa Duprey; Kristin Castorino
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

6.  Insulin Requirements and Carbohydrate to Insulin Ratio in Normal Weight, Overweight, and Obese Women With Type 1 Diabetes Under Pump Treatment During Pregnancy: A Lesson From Old Technologies.

Authors:  Camilla Festa; Raffaella Fresa; Natalia Visalli; Olimpia Bitterman; Chiara Giuliani; Concetta Suraci; Marzia Bongiovanni; Angela Napoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

7.  Time in Range in Pregnancy: Is There a Role?

Authors:  Jennifer A Wyckoff; Florence M Brown
Journal:  Diabetes Spectr       Date:  2021-05-25

Review 8.  Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.

Authors:  Guillermo E Umpierrez; David C Klonoff
Journal:  Diabetes Care       Date:  2018-06-23       Impact factor: 19.112

9.  Pregnancy in Patients with Type One Diabetes Mellitus Treated with Continuous Subcutaneous Insulin Infusion-Preconception Basal Insulin Dose as a Potential Risk Factor for Fetal Overgrowth?

Authors:  Gloria Lekšić; Maja Baretić; Marina Ivanišević; Dubravka Jurišić-Eržen
Journal:  Int J Environ Res Public Health       Date:  2020-09-09       Impact factor: 3.390

10.  Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study.

Authors:  Grenye O'Malley; Basak Ozaslan; Carol J Levy; Kristin Castorino; Donna Desjardins; Camilla Levister; Shelly McCrady-Spitzer; Mei Mei Church; Ravinder Jeet Kaur; Corey Reid; Walter K Kremers; Francis J Doyle; Mari Charisse Trinidad; Barak Rosenn; Jordan E Pinsker; Yogish C Kudva; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2021-08-17       Impact factor: 7.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.